Brace for ransomware attacks, Midsize Pharma
About 10 percent of pharmaceutical companies are highly susceptible to ransomware, a new report finds, and those with a market cap of $10 billion to $50 billion are the juiciest targets.
You don't have access to this post at the moment, but if you upgrade your account you'll be able to see the whole thing, as well as all the other posts in the archive! Subscribing will give you immediate access.